Wynzora

Active Ingredient(s): Betamethasone Dipropionate + Calcipotriene
FDA Approved: * July 20, 2020
Pharm Company: * MC2
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Wynzora Overview

Calcipotriol/betamethasone dipropionate, sold under the brand name Taclonex among others, is a fixed-dose combination medication of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis in adults and adolescents (scalp only). It is used in the form of ointment, topical suspension, and foam. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Pharmacology 4.1 Ph...

Read more Wynzora Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betamethasone/calcipotriol

Recent Wynzora Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Drugs with one or more similar ingredients: (9 results)

• BETAMETHASONE DIPROPIONATE + CALCIPOTRIENE HYDRATE
• CALCIPOTRIENE + BETAMETHASONE DIPROPIONATE
• ENSTILAR Calcipotriene + Betamethasone Dipropionate
• TACLONEX Betamethasone Dipropionate + Calcipotriene Hydrate
• TACLONEX SCALP Calcipotriene + Betamethasone Dipropionate
• CALCIPOTRIENE
• DOVONEX Calcipotriene
• SERNIVO Betamethasone Dipropionate
• SORILUX Calcipotriene